Liebermann B, Nussbaum R P, Günther W, Teuscher J M
Biologisch-Pharmazeutische Fakultät der Friedrich-Schiller-Universität Jena, Institut für Pharmazie, Germany.
Phytochemistry. 2001 Mar;56(6):551-7. doi: 10.1016/s0031-9422(00)00459-3.
By incorporation of [2-13C]-mevalonate, [1-13C]-acetate and [1-13C]-glucose we could reveal that the phytopathogenic fungus Alternaria alternata biosynthesized the mixed terpenoids bicycloalternarenes via the classic mevalonate pathway. The polyketid pathway does not participate in the biosynthesis of bicycloalternarenes, because there is no incorporation of [13C]-acetate into the C-ring of these compounds. The labelling pattern in this nonterpenoid part of bicycloalternarenes after feeding with [1-13C]-glucose and [U-13C6]-glucose, respectively, allows the assumption that metabolites of the shikimate pathway are involved.
通过掺入[2-¹³C]-甲羟戊酸、[1-¹³C]-乙酸盐和[1-¹³C]-葡萄糖,我们发现植物病原真菌链格孢通过经典的甲羟戊酸途径生物合成混合萜类双环交替芳烃。聚酮途径不参与双环交替芳烃的生物合成,因为这些化合物的C环中没有[¹³C]-乙酸盐的掺入。分别用[1-¹³C]-葡萄糖和[U-¹³C₆]-葡萄糖喂养后,双环交替芳烃这个非萜类部分的标记模式表明莽草酸途径的代谢产物参与其中。